178 related articles for article (PubMed ID: 6800179)
1. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
Okuma M
Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
[No Abstract] [Full Text] [Related]
2. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
3. Platelet function and its disorders--some aspects from the arachidonic acid metabolism.
Okuma M
Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1542-55. PubMed ID: 6442514
[No Abstract] [Full Text] [Related]
4. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
5. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
Takayama H; Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
Prostaglandins Leukot Med; 1983 Nov; 12(3):261-72. PubMed ID: 6318227
[TBL] [Abstract][Full Text] [Related]
6. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
7. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
Berild D; Hasselbalch H; Knudsen JB
Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
Petrov MN; Vashkinel' VK
Probl Gematol Pereliv Krovi; 1977 May; 22(5):18-23. PubMed ID: 267283
[No Abstract] [Full Text] [Related]
9. Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders.
Parise P; Huybrechts E; Grasselli S; Falcinelli F; Nenci GG; Gresele P; Vermylen J
Acta Haematol; 1991; 85(2):88-92. PubMed ID: 1902615
[TBL] [Abstract][Full Text] [Related]
10. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
12. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Brodsky I; Kahn SB; Ross EM; Petkov G
Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
[No Abstract] [Full Text] [Related]
13. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
Jungi WF; Meuret G; Senn HJ
Schweiz Med Wochenschr; 1974 Jan; 104(4):133-5. PubMed ID: 4521299
[No Abstract] [Full Text] [Related]
14. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
Gingold N
Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
[No Abstract] [Full Text] [Related]
15. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
16. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
17. Stainable blood platelet glycogen in various conditions.
Hermanský F; Hrodek O; Matousová O; Cieslar P
Acta Univ Carol Med Monogr; 1972; 53():165-71. PubMed ID: 4598518
[No Abstract] [Full Text] [Related]
18. [Diagnostic considerations in myelofibrosis].
Dieska D; Gocárová K; Horváth A; Vahancík A
Bratisl Lek Listy; 1970 Nov; 54(5):637-42. PubMed ID: 5276096
[No Abstract] [Full Text] [Related]
19. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
20. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
Moliterno AR; Hankins WD; Spivak JL
N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]